INNL Innocoll Holdings

2.05
0  -6%
Previous Close 2.19
Open 2.18
Price To book 0.00
Market Cap 60.98M
Shares 29,748,000
Volume 408,661
Short Ratio 0.40
Av. Daily Volume 1,670,800

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data did not meet endpoints - November 3, 2016.
Cogenzia
Diabetic foot ulcer infections
Refusal to file letter received December 29, 2016. Intends to initiate short-term Pharmacokinetic study and several short-term non-clinical studies before resubmitting NDA filing in late 2017.
XaraColl
Post-operative pain

Latest News

  1. Blog Coverage Gurnet Point Acquired Innocoll for Approximately $209 Million in Aggregate
  2. Today's Research Reports on Stocks to Watch: Aralez Pharmaceuticals and Innocoll Holdings
  3. Innocoll Holdings stock surges 33% after agreeing to up to $209 mln acquisition by Gurnet Point
  4. Gurnet Point L.P. enters into agreement to acquire Innocoll Holdings plc
  5. Gurnet Point Capital nears deal to acquire drugmaker Innocoll -sources
  6. Innocoll Holdings Plc :INNL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017
  7. Innocoll announces regulatory path forward after receiving formal FDA Type A meeting minutes regarding its XARACOLL® (bupivacaine HCl collagen-matrix implant) New Drug Application
  8. INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Innocoll Holdings plc and Encourages Investors With Losses to Contact the Firm
  9. Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc.
  10. INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Innocoll Holdings plc, and Encourages Investors with Losses Exceeding $100,000 to Contact the Firm
  11. INNL UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Innocoll Holdings plc and a Lead Plaintiff Deadline of March 27, 2017
  12. INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Innocoll Holdings plc, and Encourages Investors with Losses to Contact the Firm
  13. DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Innocoll Holdings, plc (INNL) & Lead Plaintiff Deadline: March 27, 2017
  14. Orphan Drug Status and Investor Confidence Boost Stock Prices of Moleculin Biotech and Innocoll Holdings
  15. SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Innocoll Holdings plc, and Encourages Investors with Losses Exceeding $100,000 to Contact the Firm
  16. INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Innocoll Holdings plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 – INNL
  17. Innocoll Holdings (INNL) Shows Strength: Stock Up 36.6%
  18. Innocoll reports 4Q loss
  19. Innocoll Holdings plc Announces Fourth Quarter and Full-Year 2016 Financial and Operating Results and Provides Corporate Update